tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matt Hewitt, 92 are a BUY (83.64%), 17 are a HOLD (15.45%), 1 are a SELL (0.91%).
Analyst Matt Hewitt, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 46.16% that have a potential upside of 26.91% achieved within 135 days.
Matt Hewitt’s has documented 240 price targets and ratings displayed on 19 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on BLFS, BioLife Solutions at 13-Nov-2024.
Analyst best performing recommendations are on CDXS (CODEXIS).
The best stock recommendation documented was for SLP (SIMULATIONS PLUS) at 10/25/2021. The price target of $53 was fulfilled within 10 days with a profit of $12.07 (29.49%) receiving and performance score of 29.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$12.5
$0.01 (0.08%)
$12
3 months 26 days ago
(07-Nov-2024)
9/13 (69.23%)
$0.26 (2.12%)
30
Buy
$14
$1.51 (12.09%)
$20
1 years 2 months 25 days ago
(08-Dec-2023)
4/5 (80%)
$9.36 (201.72%)
59
Buy
$16
$7.76 (94.17%)
$22
1 years 2 months 26 days ago
(08-Dec-2023)
2/6 (33.33%)
$11.36 (244.83%)
266
Buy
$20
$11.76 (142.72%)
$22
1 years 8 months 12 days ago
(22-Jun-2023)
1/4 (25%)
$6.26 (45.56%)
92
Buy
$9
$-3.49 (-27.94%)
$11
4 years 11 months 22 days ago
(11-Mar-2020)
3/3 (100%)
$4.49 (99.56%)
356
Which stock is Matt Hewitt is most bullish on?
Which stock is Matt Hewitt is most reserved on?
What Year was the first public recommendation made by Matt Hewitt?
